Reevaluating the Role of Nicotinamide Adenine Dinucleotide (NAD+) in Cellular Metabolism: A Review of Its Commercial Applications
The discovery of NAD+ as a key player in cellular metabolism has sparked significant interest in its potential therapeutic applications. However, the commercialization of NAD+ and its derivatives has been limited, with f
NAD+ is a coenzyme that plays a crucial role in various cellular processes, including energy metabolism, DNA repair, and epigenetic regulation. Despite its importance, NAD+ has been overlooked as a commercial product, with few companies actively developing and marketing NAD+-based products. In this review, we will discuss the current state of NAD+ research, its potential therapeutic applications, and the challenges associated with commercializing NAD+ and its derivatives. We will also examine the existing literature on NAD+ and its role in various diseases, including cancer, neurodegenerative disorders, and metabolic disorders. Our goal is to provide a comprehensive overview of NAD+ research and its commercial potential, highlighting the need for further research and development in this area.